Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8232986 | International Journal of Radiation Oncology*Biology*Physics | 2010 | 7 Pages |
Abstract
The results of the present study support a role for PAR2 activation in the pathogenesis of early radiation-induced intestinal injury. Pharmacologic PAR2 antagonists might have the potential to reduce the intestinal side effects of radiotherapy and/or as countermeasures in radiologic accidents or terrorism scenarios.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Junru M.D., Ph.D., Marjan Ph.D., Ashwini M.S., Morley D. M.D., Martin M.D., Ph.D.,